Antimicrobial effect of natural polyphenols with or without antibiotics on chlamydia pneumoniae infection in vitro

Microbial Drug Resistance

Volumn 20, Issue 1, 2014, Pages 1-10

  Rizzo, Antonietta ^a   Carratelli, Caterina Romano ^a   Losacco, Antonio ^a   Iovene, Maria Rosaria ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; INTERLEUKIN 17; INTERLEUKIN 23; OFLOXACIN; QUERCETIN; RESVERATROL;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; CELL PROLIFERATION; CHLAMYDIAL PNEUMONIA; CHLAMYDIASIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG INHIBITION; DRUG POTENTIATION; EPITHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR BACTERIUM; NONHUMAN; PRIORITY JOURNAL; TREATMENT FAILURE;

ANTI-BACTERIAL AGENTS; ANTIOXIDANTS; CELL LINE, TUMOR; CHLAMYDOPHILA PNEUMONIAE; CLARITHROMYCIN; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; EPITHELIAL CELLS; HUMANS; INTERLEUKIN-17; INTERLEUKIN-23; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; OFLOXACIN; QUERCETIN; STILBENES;

EID: 84893817080     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2013.0024     Document Type: Article

References (49)

1. Akai, Y., N. Nakajima, Y. Ito, T. Matsui, A. Iwasaki, and Y. Arakawa. 2007. Green tea Helicobacter pylori infection. J. Clin. Biochem. Nutr. 40:108-115.
2. Alvesalo, J., H. Vuorela, P. Tammela, M. Leinonen, P. Saikku, and P. Vuorela. 2006. Inhibitory effect of dietary phenolic compounds on Chlamydia pneumoniae in cell cultures. Biochem. Pharmacol. 71:735-741.
3. Arts, I.C., and P.C. Hollman. 2005. Polyphenols and disease risk in epidemiologic studies. Am. J. Clin. Nutr. 81:317-325.
4. Bae, S., E.M. Lee, H.J. Cha, K. Kim, Y. Yoon, H. Lee, J. Kim, Y.J. Kim, H.G. Lee, H.K. Jeung, Y.H. Min, and S. An. 2011. Resveratrol alters microRNA expression profiles in A549 human non-small cell lung cancer cells. Mol. Cells 32:243-249.
5. Bravo, L. 1998. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr. Rev. 56:317-333.
6. Carratelli, C.R., A. Rizzo, M.R. Catania, F. Gallè, E. Losi, D.L. Hasty, and F. Rossano. 2002. Chlamydia pneumoniae infections prevent the programmed cell death on THP-1 cell line. FEMS Microbiol. Lett. 215:69-74.
7. Caruso, R., D. Fina, O.A. Paoluzi, G. Del Vecchio Blanco, C. Stolfi, A. Rizzo, F. Caprioli, M. Sarra, F. Andrei, M.C. Fantini, T.T. MacDonald, F. Pallone, and G. Monteleone. 2008. IL-23-mediated regulation of IL-17 production in He-licobacter pylori-infected gastric mucosa. Eur. J. Immunol. 38:470-478.
8. Chae, H.S., H.J. Park, H.R. Hwang, A. Kwon, W.H. Lim, W.J. Yi, D.H. Han, Y.H. Kim, and J.H. Baek. 2011. The effect of antioxidants on the production of pro-inflammatory cyto-kines and orthodontic tooth movement. Mol. cells 32:189-196.
9. Coombes, B.K., and J.B. Mahony. 1999. Chlamydia pneumo-niae infection of human endothelial cells induces proliferation of smooth muscle cells via an endothelial cell-derived soluble factor(s). Infect. Immun. 67:2909-2915.
10. Dean, D., R.J. Suchland, and W.E. Stamm. 2000. Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping. J. Infect. Dis. 182:909-916.
11. Docherty, J.J., H.A. McEwen, T.J. Sweet, E. Bailey, and T.D. Booth. 2007. Resveratrol inhibition of Propionibacterium acnes. J. Antimicrob. Chemother. 59:1182-1184.
12. Epstein, S.E., Y.F. Zhou, and J. Zhu. 1999. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 100:20-28.
13. Friedman, M., P.R. Henika, and R.E. Mandrell. 2002. Bactericidal activities of plant essential oils and some of their isolated constituents against Campylobacter jejuni, Escherichia coli, Listeria monocytogenes, and Salmonella enterica. J. Food Prot. 65:1545-1560.
14. Gao, X., D. Deeb, J. Media, G. Divine, H. Jiang, R.A. Chapman, and S.C. Gautam. 2003. Immunomodulatory activity of resveratrol: discrepant in vitro and in vivo im-munological effects. Biochem. Pharmacol. 15:2427-2435.
15. Geremia, A., and D.P. Jewell. 2012. The IL-23/IL-17 pathway in inflammatory bowel disease. Expert Rev. Gastro-enterol. Hepatol. 6:223-237.
16. Gieffers, J., H. Fü llgraf, J. Jahn, M. Klinger, K. Dalhoff, H.A. Katus, W. Solbach, and M. Maass. 2001. Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment. Circulation 103:351-356.
17. Hammerschlag, M.R., K. Chirgwin, P.M. Roblin, M. Gelling, W. Dumornay, L. Mandel, P. Smith, and J. Schachter. 1992. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin. Infect. Dis. 14:178-182.
18. Kern, J.M., V. Maass, and M. Maass. 2009. Molecular pathogenesis of chronic Chlamydia pneumoniae infection: a brief overview. Clin. Microbiol. Infect. 15:36-41.
19. Khader, S.A., and R. Gopal. 2010. IL-17 in protective immunity to intracellular pathogens. Virulence 1:423-427.
20. Khader, S.A., J.E. Pearl, K. Sakamoto, L. Gilmartin, G.K. Bell, D.M. Jelley-Gibbs, N. Ghilardi, F. deSauvage, and A.M. Cooper. 2005. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available. J. Immunol. 175:788-795.
21. Kim, Y., S. Narayanan, and K.O. Chang. 2010. Inhibition of influenza virus replication by plant-derived isoquercetin. Antiviral Res. 88:227-235.
22. Kotloski, N.J., D.T. Nardelli, S.H. Peterson, J.R. Torrealba, T.F. Warner, S.M. Callister, and R.F. Shell. 2008. Inter-leukin-23 is required for development of arthritis in mice vaccinated and challenged with Borrelia species. Clin. Vaccine Immunol. 15:1199-1207.
23. Kuo, C.C., L.A. Jackson, L.A. Campbell, and J.T. Grayston. 1995. Chlamydia pneumoniae (TWAR). Clin. Microbiol. Rev. 8:451-461.
24. Kutlin, A., P.M. Roblin, and M.R. Hammerschlag. 2002. Effect of gemifloxacin on viability of Chlamydia pneumoniae (Chlamydophila pneumoniae) in an in vitro continuous infection model. J. Antimicrob. Chemother. 49:763-767.
25. Lanzilli, G., A. Cottarelli, G. Nicotera, S. Guida, G. Ra-vagnan, and M.P. Fuggetta. 2012. Anti-inflammatory effect of resveratrol and polydatin by in vitro IL-17 modulation. Inflammation 35:240-248.
26. Leinonen, M., and P. Saikku. 2002. Evidence for infectious agents in cardiovascular disease and atherosclerosis. Lancet Infect. Dis. 2:11-17.
27. Manthey, J.A. 2000. Biological properties of flavonoids pertaining to inflammation. Microcirculation 7:S29-S34.
28. Matsumoto, A., and G.P. Manire. 1970. Electron microscopic observations on the fine structure of cell walls of Chlamydia psittaci. J. Bacteriol. 104:1332-1337.
29. Middleton, E., Jr., and C. Kandaswami. 1992. Effects of flavonoids on immune and inflammatory cell functions. Biochem. Pharmacol. 43:1167-1179.
30. Mpiga, P., and M. Ravaoarinoro. 2006. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937). Int. J. Antimicrob. Agents 27:316-324.
31. Nakae, S., Y. Komiyama, A. Nambu, K. Sudo, M. Iwase, I. Homma, K. Sekikawa, M. Asano, and Y. Iwakura. 2002. Antigen-specific T cell sensitization is impaired in IL-17 deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17:375-387.
32. Naughton, P., R. Foresti, S.K. Bains, M. Hoque, C.J. Green, and R. Motterlini. 2002. Induction of heme oxygenase 1 by nitrosative stress. A role for nitroxyl anion. J. Biol. Chem. 277:40666-40674.
33. Otterbein, L.E., F.H. Bach, J. Alam, M. Soares, H. Tao Lu, M. Wysk, R.J. Davis, R.A. Flavell, and A.M. Choi. 2000. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat. Med. 6:422-428.
34. Otterbein, L.E., S.L. Otterbein, E. Ifedigbo, F. Liu, D.E. Morse, C. Fearns, R.J. Ulevitch, R. Knickelbein, R.A. Fla-vell, and A.M. Choi. 2003. MKK3 mitogen-activated protein kinase pathway mediates carbon monoxide-induced protection against oxidant-induced lung injury. Am. J. Pathol. 163:2555-2563.
35. Paolillo, R., C.R. Carratelli, and A. Rizzo. 2011. Effect of resveratrol and quercetin in experimental infection by Salmonella enterica serovar Typhimurium. Int. Immuno-pharmacol. 11:149-456.
36. Rizzo, A., M. Di Domenico, C.R. Carratelli, and R. Paolillo. 2012. The role of Chlamydia and Chlamydophila infections in reactive arthritis. Intern. Med. 51:113-117.
37. Rizzo, A., M. Di Domenico, C.R. Carratelli, N. Mazzola, and R. Paolillo. 2011. Induction of proinflammatory cytokines in human osteoblastic cells by Chlamydia pneumoniae. Cytokine 56:450-457.
38. Roblin, P.M., W. Dumornay, and M.R. Hammerschlang. 1992. Use of Hep-2 cells for improved isolation and passage of Chlamydia pneumoniae. J. Clin. Microbiol. 30:1968-1971.
39. Salin, O., S. Alakurtti, L. Pohjala, A. Siiskonen, V. Maass, M. Maass, J. Yli-Kauhaluoma, and P. Vuorela. 2010. Inhibitory effect of the natural product betulin and its derivatives against the intracellular bacterium Chlamydia pneumoniae. Biochem. Pharmacol. 80:1141-1151.
40. Salin, O.P., L.L. Pohjala, P. Saikku, H.J. Vuorela, M. Leinonen, and P.M. Vuorela. 2011. Effects of coadministration of natural polyphenols with doxycycline or calcium modulators on acute Chlamydia pneumoniae infection in vitro. J. Antibiot. (Tokyo) 64:747-752.
41. Taguri, T., T. Tanaka, and I. Kouno. 2004. Antimicrobial activity of 10 different plant polyphenols against bacteria causing food-borne disease. Biol. Pharm. Bull. 27:1965-1969.
42. Tang, C., S. Chen, H. Qian, and W. Huang. 2012. Inter-leukin-23: as a drug target for autoimmune inflammatory diseases. Immunology 135:112-124.
43. Törmäkangas, L., H. Alakärppä, D.B. David, M. Leinonen, and P. Saikku. 2004. Telithromycin treatment of chronic Chlamydia pneumoniae infection in C57BL/6J mice. Anti-microb. Agents Chemother. 48:3655-3661.
44. Törmäkangas, L., P. Vuorela, E. Saario, M. Leinonen, P. Saikku, and H. Vuorela. 2005. In vivo treatment of acute Chlamydia pneumoniae infection with the flavonoids querce-tin and luteolin and an alkyl gallate, octyl gallate, in a mouse model. Biochem. Pharmacol. 70:1222-1230.
45. Viveiros, M., C. Leandro, and L. Amaral. 2003. Myco-bacterial efflux pumps and chemotherapeutic implications. Int. J. Antimicrob. Agents 22:274-278.
46. Whittington, W.L., C. Kent, P. Kissinger, M.K. Oh, J.D. Fortenberry, S.E. Hillis, B. Litchfield, G.A. Bolan, M.E. St Louis, T.A. Farley, and H.H. Handsfield. 2001. Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: results of a multicenter cohort study. Sex Transm. Dis. 28:117-123.
47. Xuzhu, G., M. Komai-Koma, B.P. Leung, H.S. Howe, C. McSharry, I.B. McInnes, and D. Xu. 2012. Resveratrol modulates murine collagen-induced arthritis by inhibiting Th17 and B-cell function. Ann. Rheum. Dis. 71:129-135.
48. Yamazaki, T., M. Inoue, N. Sasaki, T. Hagiwara, T. Kish-imoto, S. Shiga, M. Ogawa, Y. Hara, and T. Matsumoto. 2003. In vitro inhibitory effects of tea polyphenols on the proliferation of Chlamydia trachomatis and Chlamydia pneu-moniae. Jpn. J. Infect. Dis. 56:143-145.
49. Yang, X.O., A.D. Panopoulos, R. Nurieva, S.H. Chang, D. Wang, S.S. Watowich, and C. Dong. 2007. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J. Biol. Chem. 282:9358-9363.